Home  »  Business   »  Cogent Biosciences Inc. (NASDAQ: COGT) Stock Falli...

Cogent Biosciences Inc. (NASDAQ: COGT) Stock Falling -16.47% Over A Month – Any Room For Its Value To Rise?

Cogent Biosciences Inc. (NASDAQ:COGT)’s traded shares stood at 2.0 million during the last session, with the company’s beta value hitting 1.77. At the close of trading, the stock’s price was $11.46, to imply a decrease of -2.55% or -$0.3 in intraday trading. The COGT share’s 52-week high remains $18.07, putting it -57.68% down since that peak but still an impressive 66.93% since price per share fell to its 52-week low of $3.79. The company has a valuation of $834.63M, with an average of 0.56 million shares in intraday trading volume over the past 10 days and average of 654.97K shares over the past 3 months.

Cogent Biosciences Inc. (NASDAQ:COGT) trade information

After registering a -2.55% downside in the last session, Cogent Biosciences Inc. (COGT) has traded red over the past five days. The stock hit a weekly high of 13.13 this Friday, 03/17/23, dropping -2.55% in its intraday price action. The 5-day price performance for the stock is -1.72%, and -16.47% over 30 days. With these gigs, the year-to-date price performance is -0.87%. Short interest in Cogent Biosciences Inc. (NASDAQ:COGT) saw shorts transact 4.98 million shares and set a 7.03 days time to cover.

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free.


Analysts on Wall Street suggest a consensus price target of $22.43, implying an increase of 48.91% to the stock’s current value. The extremes give us $18.00 and $28.00 for target low and target high price respectively. As such, COGT has been trading -144.33% off suggested target high and -57.07% from its likely low.

Cogent Biosciences Inc. (COGT) estimates and forecasts

Looking at statistics comparing Cogent Biosciences Inc. share performance against respective industry, we note that the company has underperformed competitors. Cogent Biosciences Inc. (COGT) shares are -30.25% down over the last 6 months, with its year-to-date growth rate lower than industry average at 8.37% against 9.60%. Revenue is forecast to grow 13.30% this quarter before jumping 27.90% for the next one.

COGT Dividends

Cogent Biosciences Inc. has its next earnings report out between May 08 and May 12. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Cogent Biosciences Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.

Cogent Biosciences Inc. (NASDAQ:COGT)’s Major holders

Cogent Biosciences Inc. insiders hold 0.01% of total outstanding shares, with institutional holders owning 112.18% of the shares at 112.18% float percentage. In total, 112.18% institutions holds shares in the company, led by Blackrock Inc. As of Sep 29, 2022, the company held over 4.6 million shares (or 6.99% of shares), all amounting to roughly $68.58 million.

The next major institution holding the largest number of shares is Commodore Capital, LP with 4.32 million shares, or about 6.57% of shares outstanding. As of the market price on Sep 29, 2022, these shares were worth $64.45 million.

We also have SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund as the top two Mutual Funds with the largest holdings of the Cogent Biosciences Inc. (COGT) shares. Going by data provided on Dec 30, 2022, SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF holds roughly 3.1 million shares. This is just over 4.72% of the total shares, with a market valuation of $35.85 million. Data from the same date shows that the other fund manager holds a little less at 2.86 million, or 4.35% of the shares, all valued at about 42.68 million.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts